Revised Medicare Fee Schedule Will Impact Endocrinologists

On December 1, 2020, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) final rule for CY 2021.

This rule updates payment policies and payment rates for Part B services furnished under the MPFS, as well as makes changes to the Quality Payment Program.

As a result of changes included in the rule, endocrinologists are expected to see a 13% increase in Medicare reimbursement while other specialties faced significant cuts. However, in an unusual move, Congress revised provisions of the Medicare regulation in its final year-end legislation to mitigate the cuts for some specialties.

Congress revised provisions of the Medicare regulation in its final year-end legislation to mitigate the cuts for some specialties.

Consequently, funding for the add-on complexity code for office E&M that would have been applied to essentially all endocrinology visits was removed and will reduce the amount of the previously predicted increase in total Medicare reimbursements for endocrinologists.

The Society has provided additional information on this reimbursement change at: www.endocrine.org/improving-practice/macra.

You may also like

  • Endocrine Society Launches Obesity Education Initiative for Members of Congress

    Obesity has been a crisis in the U.S. for decades and unfortunately it continues to impact millions of Americans. According to CDC data, approximately 42.4% of adults in the U.S. are obese, which has resulted in an estimated $147 billion in medical costs. There is also an alarming connection between obesity and COVID-19. People with obesity contracting COVID-19 are more likely to be hospitalized and placed in intensive care than those who are not obese. The…

  • Increased Funding for Research Remains a Top Endocrine Society Priority

    As Congress and the Biden administration begin work on the upcoming year’s (FY 2022) budget and appropriations priorities, the Endocrine Society will continue to advocate for increased research funding. As in previous years, the Endocrine Society will advocate for increased funding for the National Institutes of Health (NIH) and other federal research funding agencies that…

Find more in